Pathophysiology of pruritus in primary localized cutaneous amyloidosis
Authors:
- 15 March 2016
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 174 (6) , 1345-1350
Abstract
Primary localized cutaneous amyloidosis (PLCA) is a chronic pruritic dermatosis prevalent among Southern Chinese and South American populations. Pruritus is frequently present and can be debilitating; its pathophysiology is largely unknown. To investigate if small-fibre neuropathy (SFN), which results in a reduction of intraepidermal nerve fibres (IENF) and abnormalities in quantitative thermal sensory testing (QST), is present in PLCA. Twenty Chinese patients (10 men) and 20 ethnicity-, sex- and age-matched controls underwent QST assessments. The patients' warm detection threshold (WDT) and heat pain threshold at the typical lesional sites were determined. Serum interleukin (IL)-31 levels were measured. Lesional biopsies were stained for IENF, IL-31 and its receptor's subunits [IL-31RA and oncostatin M receptor-β (OSMRβ)], and nerve growth factor (NGF) and its receptor [tropomyosin receptor kinase A (TrkA)], and were compared with normal skin obtained from archival paraffin-embedded specimens. WDT was significantly higher in patients at all sites and correlated with itch scores (r = 0·59; P < 0·01). Patient biopsies revealed lower IENF counts (P < 0·01 using protein gene product 9.5, β3-tubulin and Neurofilament 200 stains) and increased epidermal expression of OSMRβ (P < 0·01) and IL-31RA (P < 0·01). Cutaneous IL-31, NGF and TrkA stains were not significantly increased in patients. Serum IL-31 was not significantly higher in patients. SFN is present in PLCA. Pruritus in PLCA is likely associated with hypersensitivity of cutaneous nerve fibres, which may be related to an increased expression of epidermal IL-31 receptors. Targeting IL-31 receptors is therefore a potential therapeutic approach.Keywords
Funding Information
- National Healthcare Group, Singapore
This publication has 29 references indexed in Scilit:
- Health-Related Quality of Life in Patients with Primary Cutaneous AmyloidosisPLOS ONE, 2015
- In Vitro Amyloidogenic Peptides of Galectin-7Journal of Biological Chemistry, 2014
- MCP-1 as an Effector of IL-31 Signaling in Familial Primary Cutaneous AmyloidosisJournal of Investigative Dermatology, 2013
- Primary localized cutaneous amyloidosis: association with atopic dermatitisJournal of the European Academy of Dermatology and Venereology, 2013
- Novel IL31RA gene mutation and ancestral OSMR mutant allele in familial primary cutaneous amyloidosisEuropean Journal of Human Genetics, 2009
- Unexpected diminished innervation of epidermis and dermoepidermal junction in lichen amyloidosusBritish Journal of Dermatology, 2008
- Oncostatin M Receptor-β Mutations Underlie Familial Primary Localized Cutaneous AmyloidosisThe American Journal of Human Genetics, 2008
- Lichen amyloidosus: A study of clinical, histopathologic and immunofluorescence findings in 30 casesIndian Journal of Dermatology, Venereology and Leprology, 2005
- Epidemiology of primary cutaneous amyloidoses in South AmericaClinics in Dermatology, 2004
- Epidemiology of primary cutaneous amyloidoses in Southeast AsiaClinics in Dermatology, 1990